HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.

AbstractOBJECTIVE:
In ovarian cancer cases, recurrence after chemotherapy is frequently observed, suggesting the involvement of ovarian cancer stem-like cells (CSCs). The chemoresistance of ovarian clear cell carcinomas is particularly strong in comparison to other epithelial ovarian cancer subtypes. We investigated the relationship between a CSC marker, aldehyde dehydrogenase 1 (ALDH1), and clinical prognosis using ovarian clear cell carcinoma tissue samples. Furthermore, we investigated the antioxidant mechanism by which CSCs maintain a lower reactive oxygen species (ROS) level, which provides protection from chemotherapeutic agents.
METHODS:
Immunohistochemical staining was performed to examine the CSC markers (CD133, CD44, ALDH1) using ovarian clear cell carcinoma tissue samples (n=81). Clear cell carcinoma cell lines (KOC-7C, OVTOKO) are separated into the ALDH-high and ALDH-low populations by ALDEFLUOR assay and fluorescence-activated cell sorting (FACS). We compared the intracellular ROS level, mRNA level of the antioxidant enzymes and Nrf2 expression of the two populations.
RESULTS:
High ALDH1 expression levels are related to advanced stage in clear cell carcinoma cases. ALDH1 expression significantly reduced progression free survival. Other markers are not related to clinical stage and prognosis. ALDH-high cells contained a lower ROS level than ALDH-low cells. Antioxidant enzymes were upregulated in ALDH-high cells. ALDH-high cells showed increased expression of Nrf2, a key transcriptional factor of the antioxidant system.
CONCLUSIONS:
ALDH-positive CSCs might have increased Nrf2-induced antioxidant scavengers, which lower ROS level relevant to chemoresistance in ovarian clear cell carcinoma.
AuthorsT Mizuno, N Suzuki, H Makino, T Furui, E Morii, H Aoki, T Kunisada, M Yano, S Kuji, Y Hirashima, A Arakawa, S Nishio, K Ushijima, K Ito, Y Itani, K Morishige
JournalGynecologic oncology (Gynecol Oncol) Vol. 137 Issue 2 Pg. 299-305 (May 2015) ISSN: 1095-6859 [Electronic] United States
PMID25541259 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Isoenzymes
  • Reactive Oxygen Species
  • Aldehyde Dehydrogenase 1 Family
  • ALDH1A1 protein, human
  • Retinal Dehydrogenase
Topics
  • Adenocarcinoma, Clear Cell (metabolism, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Aldehyde Dehydrogenase 1 Family
  • Carcinoma, Ovarian Epithelial
  • Cell Line, Tumor
  • Female
  • Humans
  • Immunohistochemistry
  • Isoenzymes (metabolism)
  • Middle Aged
  • Neoplasms, Glandular and Epithelial (metabolism, pathology)
  • Neoplastic Stem Cells (enzymology, metabolism, pathology)
  • Ovarian Neoplasms (metabolism, pathology)
  • Prognosis
  • Reactive Oxygen Species (metabolism)
  • Retinal Dehydrogenase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: